Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic

Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating infla...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pediatrics 2021-07, Vol.9
Main Authors: Baresi, Giulia, Giacomelli, Mauro, Moratto, Daniele, Chiarini, Marco, Conforti, Immacolata Claudia, Padoan, Rita, Poli, Piercarlo, Timpano, Silviana, Caldarale, Francesca, Badolato, Raffaele
Format: Article
Language:English
Subjects:
cystic fibrosis
cytokines
inflammatory activation
Pediatrics
SARS-CoV-2 infection
T cell activation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating inflammatory markers. One of them developed COVID - 19, giving us the possibility to analyze inflammatory markers in the acute phase as compared to levels detected before and after the infectious episode and to levels measured in the other CF patients enrolled to the study who did not experience COVID-19 and 23 patients referred to our center for SARS-CoV-2 infection.
ISSN:2296-2360
2296-2360
DOI:10.3389/fped.2021.645063